LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · IEX Real-Time Price · USD
65.46
+2.47 (3.92%)
Apr 26, 2024, 4:00 PM EDT - Market closed
LeMaitre Vascular Revenue
In the year 2023, LeMaitre Vascular had annual revenue of $193.48M with 19.69% growth. Revenue in the quarter ending December 31, 2023 was $48.88M with 19.36% year-over-year growth.
Revenue (ttm)
$193.48M
Revenue Growth
+19.69%
P/S Ratio
7.53
Revenue / Employee
$307,117
Employees
630
Market Cap
1.46B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 193.48M | 31.83M | 19.69% |
Dec 31, 2022 | 161.65M | 7.23M | 4.68% |
Dec 31, 2021 | 154.42M | 25.06M | 19.37% |
Dec 31, 2020 | 129.37M | 12.13M | 10.35% |
Dec 31, 2019 | 117.23M | 11.66M | 11.05% |
Dec 31, 2018 | 105.57M | 4.70M | 4.66% |
Dec 31, 2017 | 100.87M | 11.72M | 13.14% |
Dec 31, 2016 | 89.15M | 10.80M | 13.78% |
Dec 31, 2015 | 78.35M | 7.26M | 10.20% |
Dec 31, 2014 | 71.10M | 6.55M | 10.14% |
Dec 31, 2013 | 64.55M | 7.81M | 13.77% |
Dec 31, 2012 | 56.74M | -950.00K | -1.65% |
Dec 31, 2011 | 57.69M | 1.63M | 2.90% |
Dec 31, 2010 | 56.06M | 5.15M | 10.12% |
Dec 31, 2009 | 50.91M | 2.19M | 4.49% |
Dec 31, 2008 | 48.72M | 7.27M | 17.55% |
Dec 31, 2007 | 41.45M | 6.82M | 19.69% |
Dec 31, 2006 | 34.63M | 3.90M | 12.70% |
Dec 31, 2005 | 30.73M | 4.54M | 17.35% |
Dec 31, 2004 | 26.18M | 5.52M | 26.71% |
Dec 31, 2003 | 20.66M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
National HealthCare | 1.14B |
InMode | 492.05M |
Veracyte | 361.05M |
Dynavax Technologies | 232.28M |
Arcus Biosciences | 117.00M |
Gyre Therapeutics | 113.45M |
Protagonist Therapeutics | 60.00M |
LMAT News
- 7 days ago - LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024 - GlobeNewsWire
- 4 weeks ago - LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 2 months ago - LeMaitre to Participate at Upcoming Investor Conferences in March - GlobeNewsWire
- 2 months ago - LeMaitre Q4 2023 Financial Results - GlobeNewsWire
- 2 months ago - LeMaitre Will Announce Fourth Quarter 2023 Earnings Results February 27, 2024 - GlobeNewsWire
- 3 months ago - LeMaitre to Present at the 26th Annual Needham Growth Conference - GlobeNewsWire
- 6 months ago - LeMaitre to Participate at Upcoming Investor Conferences in November - GlobeNewsWire
- 6 months ago - LeMaitre Q3 2023 Financial Results - GlobeNewsWire